Financial reports
No filings
Current reports
No filings
Registration and prospectus
No filings
Proxies
DFAN14A
Additional proxy materials by non-management
16 May 24
DFAN14A
Additional proxy materials by non-management
8 May 24
DFAN14A
Additional proxy materials by non-management
3 May 24
DFAN14A
Additional proxy materials by non-management
1 May 24
DFAN14A
Additional proxy materials by non-management
29 Apr 24
DFAN14A
Additional proxy materials by non-management
29 Apr 24
DFAN14A
Additional proxy materials by non-management
17 Apr 24
DEFC14A
Proxy in contested solicitation
17 Apr 24
PRRN14A
Revised preliminary proxy statement filed by non-management
2 Apr 24
PRRN14A
Revised preliminary proxy statement filed by non-management
26 Mar 24
Other
No filings
Ownership
4
David Efraim Rosen
17 Jun 24
SC 13D/A
Mereo BioPharma Group plc
17 Jun 24
SC 13D/A
Xperi Inc.
11 Jun 24
SC 13D/A
Xperi Inc.
31 May 24
SC 13D/A
HERON THERAPEUTICS, INC. /DE/
31 May 24
13F-HR
Quarterly holdings report by institutional manager
10 May 24
SC 13D/A
Mereo BioPharma Group plc
16 Apr 24
SC 13D/A
Xperi Inc.
21 Feb 24
SC 13D/A
Xperi Inc.
14 Feb 24
13F-HR
Quarterly holdings report by institutional manager
13 Feb 24